{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:45:43Z","timestamp":1792035943460,"version":"4.4.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["GO565\/16-1"],"award-info":[{"award-number":["GO565\/16-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejpb.2015.05.016","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T20:27:21Z","timestamp":1432931241000},"page":"227-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"special_numbering":"PB","title":["Hydrogels in ophthalmic applications"],"prefix":"10.1016","volume":"95","author":[{"given":"Susanne","family":"Kirchhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim M.","family":"Goepferich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand P.","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2015.05.016_b0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejpb.2015.05.016_b0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archophthalmol.2009.58","article-title":"Forecasting age-related macular degeneration through the year 2050","volume":"127","author":"Rein","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0020","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2015.05.016_b0025","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0142-9612(00)00237-4","article-title":"Ocular biomaterials and implants","volume":"22","author":"Lloyd","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/17469899.2.2.255","article-title":"Recent advances in polymeric vitreous substitutes","volume":"2","author":"Swindle","year":"2007","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0035","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.actbio.2010.10.030","article-title":"Towards an ideal biomaterial for vitreous replacement: historical overview and future trends","volume":"7","author":"Baino","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2015.05.016_b0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3129\/i08-076","article-title":"Multicenter study of compliance and drop administration in glaucoma","volume":"43","author":"Kholdebarin","year":"2008","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0045","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jps.2600650909","article-title":"Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes","volume":"65","author":"Patton","year":"1976","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jps.2600680606","article-title":"Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits","volume":"68","author":"Lee","year":"1979","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"J\u00e4rvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2015.05.016_b0060","first-page":"961","article-title":"Drug delivery for posterior segment eye disease","volume":"41","author":"Geroski","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems: a shift to the posterior segment","volume":"13","author":"del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2015.05.016_b0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/ICU.0b013e328330ccb9","article-title":"Recent advances in drug delivery systems for treating ocular complications of systemic diseases","volume":"20","author":"Lee","year":"2009","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0075","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0080","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ophtha.2008.08.012","article-title":"Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration","volume":"115","author":"Ip","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.05.016_b0085","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2012.07.058","article-title":"Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema","volume":"119","author":"Ho","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.05.016_b0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1350-9462(01)00017-9","article-title":"Microemulsions as ocular drug delivery systems: recent developments and future challenges","volume":"21","author":"Vandamme","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0105","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1073\/pnas.1220281110","article-title":"Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application","volume":"110","author":"Pollinger","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejpb.2015.05.016_b0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2013.07.002","article-title":"Developing an in situ nanosuspension: a novel approach towards the efficient administration of poorly soluble drugs at the anterior eye","volume":"50","author":"Luschmann","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0115","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable implants for sustained drug release in the eye","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0120","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer"},{"key":"10.1016\/j.ejpb.2015.05.016_b0125","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11095-008-9801-2","article-title":"PEG hydrogels for the controlled release of biomolecules in regenerative medicine","volume":"26","author":"Lin","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0130","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1021\/cr200157d","article-title":"Hydrogels for protein delivery","volume":"112","author":"Vermonden","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2015.05.016_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.01.057","article-title":"In situ gelling hydrogels for pharmaceutical and biomedical applications","volume":"355","author":"Van Tomme","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0140","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/S0142-9612(01)00165-X","article-title":"Soft contact lens polymers: an evolution","volume":"22","author":"Nicolson","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0145","first-page":"63","article-title":"Foldable intraocular lenses","author":"Werner","year":"2005"},{"key":"10.1016\/j.ejpb.2015.05.016_b0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jcrs.2006.11.020","article-title":"Meta-analysis of accommodating intraocular lenses","volume":"33","author":"Findl","year":"2007","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2015.05.016_b0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0169-409X(95)00015-Y","article-title":"Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels","volume":"16","author":"Zignani","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2015.05.016_b0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/17425247.2012.665367","article-title":"In situ gel systems as \u201csmart\u201d carriers for sustained ocular drug delivery","volume":"9","author":"Agrawal","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2015.05.016_b0165","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1039\/b719791h","article-title":"Ophthalmic adhesives: a materials chemistry perspective","volume":"18","author":"Oelker","year":"2008","journal-title":"J. Mater. Chem."},{"issue":"2011","key":"10.1016\/j.ejpb.2015.05.016_b0170","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1351\/PAC-REC-10-06-03","article-title":"Terminology of polymers and polymerization processes in dispersed systems (IUPAC Recommendations 2011)","volume":"83","author":"Slomkowski","year":"2011","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejpb.2015.05.016_b0175","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/cr000108x","article-title":"Hydrogels for tissue engineering","volume":"101","author":"Lee","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2015.05.016_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00239-3","article-title":"Hydrogels for biomedical applications","volume":"54","author":"Hoffman","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2015.05.016_b0185","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/S0142-9612(03)00340-5","article-title":"Hydrogels for tissue engineering: scaffold design variables and applications","volume":"24","author":"Drury","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0190","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1021\/bc200281k","article-title":"Regenerative biomaterials that \u201cclick\u201d: simple, aqueous-based protocols for hydrogel synthesis, surface immobilization, and 3D patterning","volume":"22","author":"Nimmo","year":"2011","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejpb.2015.05.016_b0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mabi.201400379","article-title":"Protein compatibility of selected cross-linking reactions for hydrogels","volume":"15","author":"Hammer","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2014.03.031","article-title":"Cleavable carbamate linkers for controlled protein delivery from hydrogels","volume":"183","author":"Hammer","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1021\/bm301352x","article-title":"Protein-polyanion interactions for the controlled release of monoclonal antibodies","volume":"14","author":"Schweizer","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2015.05.016_b0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/bm501063n","article-title":"Formulation of in situ chemically cross-linked hydrogel depots for protein release: from the blob model perspective","volume":"16","author":"Yu","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2015.05.016_b0215","first-page":"19","article-title":"Ocular pharmacokinetics","author":"Maurice","year":"1984"},{"key":"10.1016\/j.ejpb.2015.05.016_b0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/10837450801949566","article-title":"Alginate inserts loaded with epidermal growth factor for the treatment of keratoconjunctivitis sicca","volume":"13","author":"Koelwel","year":"2008","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0225","first-page":"130","article-title":"Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma","volume":"56","author":"Gurny","year":"1981","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ejpb.2015.05.016_b0230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0168-3659(85)90057-4","article-title":"Ocular therapy with nanoparticulate systems for controlled drug delivery","volume":"2","author":"Gurny","year":"1985","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0168-3659(87)90090-3","article-title":"Design and evaluation of controlled release systems for the eye","volume":"6","author":"Gurny","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0240","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1023\/A:1015813225804","article-title":"Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions","volume":"8","author":"Davies","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0168-3659(01)00279-6","article-title":"Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system","volume":"73","author":"Srividya","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1248\/yakushi.127.183","article-title":"Preparation and evaluation of a Carbopol\u00ae\/HPMC-based in situ gelling ophthalmic system for puerarin","volume":"127","author":"Wu","year":"2007","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejpb.2015.05.016_b0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5173(82)90114-4","article-title":"Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits","volume":"12","author":"Miller","year":"1982","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0260","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/js970090e","article-title":"In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine","volume":"87","author":"Desai","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","article-title":"In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate","volume":"241","author":"El-Kamel","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0168-3659(00)00329-1","article-title":"Carbopol\/pluronic phase change solutions for ophthalmic drug delivery","volume":"69","author":"Lin","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0275","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2006.12.038","article-title":"Development of a poloxamer analogs\/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin","volume":"337","author":"Qi","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2007.09.005","article-title":"Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system","volume":"350","author":"Ma","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0285","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0142-9612(01)00127-2","article-title":"Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide","volume":"23","author":"Hsiue","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0290","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2007.05.009","article-title":"Poly(N-isopropylacrylamide)\u2013chitosan as thermosensitive in situ gel-forming system for ocular drug delivery","volume":"120","author":"Cao","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5173(01)00825-0","article-title":"In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride","volume":"229","author":"Miyazaki","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0300","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0008-6215(83)88361-X","article-title":"Structural studies of gellan gum, an extracellular polysaccharide elaborated by Pseudomonas elodea","volume":"124","author":"Jansson","year":"1983","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(89)90305-0","article-title":"Gelrite\u00ae: a novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol","volume":"57","author":"Rozier","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-3659(93)90186-9","article-title":"Gellan-based systems for ophthalmic sustained delivery of methylprednisolone","volume":"26","author":"Sanzgiri","year":"1993","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/713840402","article-title":"Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride","volume":"10","author":"Balasubramaniam","year":"2003","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2015.05.016_b0320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10717540500309164","article-title":"Ion-activated, Gelrite\u00ae-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops","volume":"13","author":"Sultana","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2015.05.016_b0325","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/2230-973X.100042","article-title":"Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride","volume":"2","author":"Mandal","year":"2012","journal-title":"Int. J. Pharm. Invest."},{"key":"10.1016\/j.ejpb.2015.05.016_b0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2006.01.029","article-title":"Study of an alginate\/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin","volume":"315","author":"Liu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0335","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-010-9413-0","article-title":"In situ gelling Gelrite\/alginate formulations as vehicles for ophthalmic drug delivery","volume":"11","author":"Liu","year":"2010","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2015.05.016_b0340","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/bm0496965","article-title":"In situ gelling of alginate\/Pluronic solutions for ophthalmic delivery of pilocarpine","volume":"5","author":"Lin","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2015.05.016_b0345","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/185117a0","article-title":"Hydrophilic gels for biological use","volume":"185","author":"Wichterle","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2015.05.016_b0350","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00006324-199801000-00022","article-title":"Oxygen permeability of a new type of high Dk soft contact lens material","volume":"75","author":"Alvord","year":"1998","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0355","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clae.2006.03.004","article-title":"Clinical performance of daily disposable soft contact lenses using sustained release technology","volume":"29","author":"Peterson","year":"2006","journal-title":"Cont. Lens Anterior Eye."},{"key":"10.1016\/j.ejpb.2015.05.016_b0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/17434440.3.2.167","article-title":"Soft contact lens biomaterials from bioinspired phospholipid polymers","volume":"3","author":"Goda","year":"2006","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.ejpb.2015.05.016_b0365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00137696-200604030-00002","article-title":"Contact lenses for drug delivery","volume":"4","author":"Alvarez-Lorenzo","year":"2006","journal-title":"Am. J. Drug Deliv."},{"key":"10.1016\/j.ejpb.2015.05.016_b0370","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clae.2007.09.002","article-title":"Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review","volume":"31","author":"Xinming","year":"2008","journal-title":"Cont. Lens Anterior Eye."},{"key":"10.1016\/j.ejpb.2015.05.016_b0375","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/17425247.2013.821462","article-title":"Contact lenses as a platform for ocular drug delivery","volume":"10","author":"Bengani","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2015.05.016_b0380","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2015.01.023","article-title":"Sustained drug release by contact lenses for glaucoma treatment \u2013 a review","volume":"202","author":"Carvalho","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0385","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00055735-200408000-00005","article-title":"Advances in the use of adhesives in ophthalmology","volume":"15","author":"Chan","year":"2004","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0390","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/bm101562v","article-title":"Bioinspired imprinted PHEMA-hydrogels for ocular delivery of carbonic anhydrase inhibitor drugs","volume":"12","author":"Ribeiro","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2015.05.016_b0395","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1542-0124(12)70041-1","article-title":"Ocular surface sealants and adhesives","volume":"4","author":"Bhatia","year":"2006","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejpb.2015.05.016_b0400","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1586\/erd.10.40","article-title":"Novel wound sealants: biomaterials and applications","volume":"7","author":"Peng","year":"2010","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.ejpb.2015.05.016_b0405","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00006982-200005000-00007","article-title":"Bioadhesives for intraocular use","volume":"20","author":"Margalit","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.ejpb.2015.05.016_b0410","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jbm.b.30439","article-title":"Gelatin-based biomimetic tissue adhesive. Potential for retinal reattachment","volume":"77B","author":"Chen","year":"2006","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0415","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10384-006-0405-2","article-title":"Intraocular use of hydrogel tissue adhesive in rabbit eyes","volume":"51","author":"Sueda","year":"2007","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0420","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.biomaterials.2009.10.010","article-title":"Doxycycline loaded poly(ethylene glycol) hydrogels for healing vesicant-induced ocular wounds","volume":"31","author":"Anumolu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0425","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/jop.2010.0099","article-title":"Doxycycline hydrogels as a potential therapy for ocular vesicant injury","volume":"26","author":"Gordon","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2015.05.016_b0430","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1076\/ceyr.16.3.183.15403","article-title":"A semi-solid drug delivery system for epidermal growth factor in corneal epithelial wound healing","volume":"16","author":"Sheardown","year":"1997","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2006.12.011","article-title":"Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing","volume":"118","author":"Hori","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2015.05.016_b0440","first-page":"1","article-title":"New hydrophobic IOL materials and understanding the science of glistenings","author":"Tetz","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0445","first-page":"183","article-title":"Surface modification of hydrogel intraocular lenses to prevent cell proliferation","volume":"2","author":"Helary","year":"2004","journal-title":"J. Appl. Biomater. Biomech."},{"key":"10.1016\/j.ejpb.2015.05.016_b0450","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1021\/bm0701649","article-title":"Improved performances of intraocular lenses by poly(ethylene glycol) chemical coatings","volume":"8","author":"Bozukova","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2015.05.016_b0455","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jp066217i","article-title":"Novel porphyrin-incorporated hydrogels for photoactive intraocular lens biomaterials","volume":"111","author":"Brady","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2015.05.016_b0460","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/ma4111927","article-title":"Drug-eluting intraocular lenses","volume":"4","author":"Gonz\u00e1lez-Chom\u00f3n","year":"2011","journal-title":"Materials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0465","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/ICU.0b013e32835a93fc","article-title":"Intraocular lens as a drug delivery reservoir","volume":"24","author":"Liu","year":"2013","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0470","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0079-6700(97)00045-2","article-title":"The use of hydrophilic polymers as artificial vitreous","volume":"23","author":"Chirila","year":"1998","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0475","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0142-9612(99)00220-3","article-title":"Biomaterials used in the posterior segment of the eye","volume":"21","author":"Colthurst","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0480","first-page":"59","article-title":"Artificial vitreous replacements","volume":"13","author":"Soman","year":"2003","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.ejpb.2015.05.016_b0485","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.survophthal.2010.09.001","article-title":"Vitreous substitutes: a comprehensive review","volume":"56","author":"Kleinberg","year":"2011","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0490","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00006982-199004000-00012","article-title":"Evaluation of a viscoelastic solution of hydroxypropyl methylcellulose as a potential vitreous substitute","volume":"10","author":"Fernandez-Vigo","year":"1990","journal-title":"Retina"},{"key":"10.1016\/j.ejpb.2015.05.016_b0495","first-page":"71","article-title":"ADCON-L hydrogel as a vitreous substitute: preliminary results","author":"De Jong","year":"2000","journal-title":"Bull. Soc. Belge Ophtalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0500","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbm.a.30917","article-title":"In vitro evaluation of in situ gels as short term vitreous substitutes","volume":"79A","author":"Suri","year":"2006","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0505","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jbm.820050108","article-title":"Polymers in ophthalmic surgery","volume":"5","author":"Refojo","year":"1971","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0510","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jbm.820100615","article-title":"Development of injectable poly(glyceryl methacrylate) hydrogels for vitreous prosthesis","volume":"10","author":"Hogen-Esch","year":"1976","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0515","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00006982-199010000-00013","article-title":"Ocular toxicity of vitreal pluronic polyol F-127","volume":"10","author":"Davidorf","year":"1990","journal-title":"Retina"},{"key":"10.1016\/j.ejpb.2015.05.016_b0520","first-page":"811","article-title":"Evaluation of silicone gel as a long-term vitreous substitute in non-human primates","volume":"23","author":"Peyman","year":"1992","journal-title":"Ophthalmic Surg."},{"key":"10.1016\/j.ejpb.2015.05.016_b0525","series-title":"Polymer Gels","first-page":"127","article-title":"Synthetic vitreous body of PVA hydrogel","author":"Yamauchi","year":"1991"},{"key":"10.1016\/j.ejpb.2015.05.016_b0530","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-4636(199604)30:4<441::AID-JBM2>3.0.CO;2-P","article-title":"Crosslinked poly(1-vinyl-2-pyrrolidinone) as a vitreous substitute","volume":"30","author":"Hong","year":"1996","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0535","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s10856-010-4092-7","article-title":"PVA\/STMP based hydrogels as potential substitutes of human vitreous","volume":"21","author":"Leone","year":"2010","journal-title":"J. Mater. Sci. \u2013 Mater. Med."},{"key":"10.1016\/j.ejpb.2015.05.016_b0540","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1167\/iovs.08-2891","article-title":"Rabbit study of an in situ forming hydrogel vitreous substitute","volume":"50","author":"Swindle-Reilly","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0545","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1016\/j.actbio.2012.09.026","article-title":"Evaluation of an in situ chemically crosslinked hydrogel as a long-term vitreous substitute material","volume":"9","author":"Tao","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2015.05.016_b0550","first-page":"169","article-title":"Fine structure and function of ocular tissues. The vitreous","volume":"13","author":"Balazs","year":"1973","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.ejpb.2015.05.016_b0555","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1167\/iovs.11-7322","article-title":"The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute","volume":"53","author":"Schramm","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0560","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1163\/092050610X522729","article-title":"An injectable oxidated hyaluronic acid\/adipic acid dihydrazide hydrogel as a vitreous substitute","volume":"22","author":"Su","year":"2011","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ejpb.2015.05.016_b0565","doi-asserted-by":"crossref","DOI":"10.1038\/srep01838","article-title":"A novel vitreous substitute of using a foldable capsular vitreous body injected with polyvinylalcohol hydrogel","volume":"3","author":"Feng","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2015.05.016_b0570","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0575","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0580","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1172\/JCI65509","article-title":"Turning a blind eye to anti-VEGF toxicities","volume":"122","author":"Quaggin","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejpb.2015.05.016_b0585","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","article-title":"Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Grunwald","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2015.05.016_b0590","first-page":"206","article-title":"Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye","volume":"106","author":"Kang Derwent","year":"2008","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.ejpb.2015.05.016_b0595","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.biomaterials.2011.01.058","article-title":"The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function","volume":"32","author":"Turturro","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0600","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1167\/iovs.13-13120","article-title":"Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo","volume":"55","author":"Rauck","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0605","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/adem.200700221","article-title":"Poly(ethylene glycol) based hydrogels for intraocular applications","volume":"9","author":"Brandl","year":"2007","journal-title":"Adv. Eng. Mater."},{"key":"10.1016\/j.ejpb.2015.05.016_b0610","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2014.04.053","article-title":"In situ covalently cross-linked PEG hydrogel for ocular drug delivery applications","volume":"470","author":"Yu","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.05.016_b0615","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.4.2.5","article-title":"Injectable chemically crosslinked hydrogel for the controlled release of bevacizumab in vitreous: a 6-month in vivo study","volume":"4","author":"Yu","year":"2015","journal-title":"Trans. Vis. Sci. Technol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0620","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/masy.201100049","article-title":"In vitro and in vivo evaluation of a multifunctional hyaluronic acid based hydrogel system for local application on the retina","volume":"309\u2013310","author":"Neffe","year":"2011","journal-title":"Macromol. Symp."},{"key":"10.1016\/j.ejpb.2015.05.016_b0625","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-0-387-34133-0_27","article-title":"Ocular tissue engineering","author":"Sommer","year":"2007"},{"key":"10.1016\/j.ejpb.2015.05.016_b0630","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1167\/iovs.06-0190","article-title":"Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate","volume":"48","author":"Canola","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0635","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1634\/stemcells.2007-0653","article-title":"Adipose-derived stem cells are a source for cell therapy of the corneal stroma","volume":"26","author":"Arnalich-Montiel","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.ejpb.2015.05.016_b0640","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMoa0905955","article-title":"Limbal stem-cell therapy and long-term corneal regeneration","volume":"363","author":"Rama","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2015.05.016_b0645","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0014-4835(03)00209-4","article-title":"Prospects for endothelial transplantation","volume":"78","author":"Engelmann","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0650","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa040455","article-title":"Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium","volume":"351","author":"Nishida","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2015.05.016_b0655","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.tp.0000287336.09848.39","article-title":"Tissue-engineered human corneal endothelial cell sheet transplantation in a rabbit model using functional biomaterials","volume":"84","author":"Lai","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ejpb.2015.05.016_b0660","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archopht.124.10.1441","article-title":"Bioengineered human corneal endothelium for transplantation","volume":"124","author":"Lai","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejpb.2015.05.016_b0665","doi-asserted-by":"crossref","unstructured":"B. Ozcelik, K.D. Brown, A. Blencowe, M. Daniell, G.W. Stevens, G.G. Qiao, Ultrathin chitosan\u2013poly(ethylene glycol) hydrogel films for corneal tissue engineering, Acta Biomater. 9 (n.d.) 6594\u20136605. http:\/\/dx.doi.org\/10.1016\/j.actbio.2013.01.020.","DOI":"10.1016\/j.actbio.2013.01.020"},{"key":"10.1016\/j.ejpb.2015.05.016_b0670","first-page":"1819","article-title":"Tissue engineering of corneal stroma with rabbit fibroblast precursors and gelatin hydrogels","volume":"14","author":"Mimura","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2015.05.016_b0675","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1016\/j.apsusc.2009.04.206","article-title":"Study on a hydroxypropyl chitosan\u2013gelatin based scaffold for corneal stroma tissue engineering","volume":"255","author":"Wang","year":"2009","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0680","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.msec.2010.02.024","article-title":"Evaluation of cross-linked gelatin membranes as delivery carriers for retinal sheets","volume":"30","author":"Lai","year":"2010","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2015.05.016_b0685","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nature05161","article-title":"Retinal repair by transplantation of photoreceptor precursors","volume":"444","author":"MacLaren","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2015.05.016_b0690","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.preteyeres.2004.01.002","article-title":"Stem cells and retinal repair","volume":"23","author":"Klassen","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0695","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1634\/stemcells.2005-0111","article-title":"Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells","volume":"23","author":"Tomita","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.ejpb.2015.05.016_b0700","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.biomaterials.2009.12.004","article-title":"A hydrogel-based stem cell delivery system to treat retinal degenerative diseases","volume":"31","author":"Ballios","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2015.05.016_b0705","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/ten.tea.2012.0209","article-title":"The application of hyaluronic acid hydrogels to retinal progenitor cell transplantation","volume":"19","author":"Liu","year":"2013","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.ejpb.2015.05.016_b0710","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s13770-012-0355-3","article-title":"Intravitreal delivery of mesenchymal stem cells loaded onto hydrogel affects the regulatory expression of endogenous NGF and BDNF in ischemic rat retina","volume":"9","author":"Lee","year":"2012","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.ejpb.2015.05.016_b0715","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.actbio.2013.09.029","article-title":"Thiolated hyaluronan-based hydrogels crosslinked using oxidized glutathione: an injectable matrix designed for ophthalmic applications","volume":"10","author":"Zarembinski","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2015.05.016_b0720","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/jbm.a.34021","article-title":"Cell-adhesive thermogelling PNIPAAm\/hyaluronic acid cell delivery hydrogels for potential application as minimally invasive retinal therapeutics","volume":"100A","author":"Mazumder","year":"2012","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0725","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1016\/j.actbio.2013.04.048","article-title":"A tunable synthetic hydrogel system for culture of retinal ganglion cells and amacrine cells","volume":"9","author":"Hertz","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2015.05.016_b0730","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jbm.a.31811","article-title":"Effects of sterilization on poly(ethylene glycol) hydrogels","volume":"87A","author":"Kanjickal","year":"2008","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0735","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/bit.23105","article-title":"Application of a dense gas technique for sterilizing soft biomaterials","volume":"108","author":"Karajanagi","year":"2011","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ejpb.2015.05.016_b0740","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1023\/A:1025771421906","article-title":"Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation","volume":"20","author":"Chi","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2015.05.016_b0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.20727","article-title":"Antibody structure, instability, and formulation","volume":"96","author":"Wang","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2015.05.016_b0750","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0883911506064368","article-title":"Internal osmotic pressure as a mechanism of retinal attachment in a vitreous substitute","volume":"21","author":"Foster","year":"2006","journal-title":"J. Bioact. Compat. Polym."},{"key":"10.1016\/j.ejpb.2015.05.016_b0755","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s10856-010-4035-3","article-title":"Biocompatibility of chemically cross-linked gelatin hydrogels for ophthalmic use","volume":"21","author":"Lai","year":"2010","journal-title":"J. Mater. Sci. \u2013 Mater. Med."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641115002489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641115002489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T17:02:43Z","timestamp":1566752563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641115002489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":151,"alternative-id":["S0939641115002489"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.05.016","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogels in ophthalmic applications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}